孟鲁司特钠联合卡介菌多糖核酸在儿科哮喘治疗中应用效果分析.doc

孟鲁司特钠联合卡介菌多糖核酸在儿科哮喘治疗中应用效果分析 　　[摘要] 目的 探?孟鲁司特钠联合卡介菌多糖核酸在儿科哮喘治疗中的应用效果。方法 纳入100例为方便选择自2014年1月―2017年5月期间的儿科哮喘患儿为研究对象；根据哮喘患儿的入院时间先后次序分为两组，对照组单一采用孟鲁司特钠治疗，研究组采用孟鲁司特钠联合卡介菌多糖核酸治疗；比较分析两组哮喘患儿的临床治疗效果及改善情况。结果 对照组治疗效果（72.00%）明显低于研究组（94.00%），差异有统计学意义（P0.05）；治疗后两组均有改善，而研究组改善幅度更大，差异有统计学意义（P0.05）；对照组不良反应发生率（12.00%）明显高于研究组（2.00%），差异有统计学意义（P0.05）。结论 在儿科哮喘治疗中给予哮喘患儿应用孟鲁司特钠联合卡介菌多糖核酸的临床应用效果显著，值得临床推广与应用。 　　[关键词] 哮喘；孟鲁司特钠；卡介茵多糖核酸；临床效果；哮喘症状评分 　　[中图分类号] R5 [文献标识码] A [文章编号] 1674-0742（2018）01（a）-0128-03 　　Therapeutic Effect of Montelukast Combined with BCG Polysaccharide Nucleic Acid in the Treatment of Pediatric Asthma 　　ZHAO Xiu-fang 　　Pediatric Department， Tonghua Second People’s Hospital， Tonghua， Jilin Province， 134003 China 　　[Abstract] Objective This paper tries to investigate the efficacy of Montelukast combined with BCG polysaccharide nucleic acid in the treatment of pediatric asthma. Methods A total of 100 children with pediatric asthma were conveniently selected from January 2014 to May 2017. The patients were divided into two groups according to the order of admission of asthma. The control group was treated with montelukast sodium alone. The combination of montelukast sodium combined with BCG polysaccharide nucleic acid treatment； comparative analysis of the two groups of children with asthma clinical treatment and improvement of the situation. Results The effect of treatment of the control group （72.00%） was significantly lower than that of the study group（94.00%）difference are statistically significant（P0.05）； the two groups after treatment were improved， and the study group improved more significantly， difference are statistically significant（P0.05）； adverse reaction rate of the control group （12.00%） was significantly higher than that of the study group （2.00%）， difference are statistically significant（P0.05）. Conclusion The clinical application of Montelukast Combined with BCG polysaccharide nucleic acid in the treatment of asthma in children is significant， and it is